April 18, 2014 6:39 PM ET

Life Sciences Tools and Services

Company Overview of MerLion Pharmaceuticals Pte. Ltd.

Company Overview

MerLion Pharmaceuticals Pte. Ltd., drug discovery and development company, engages in the research and development of natural products. It operates through two business units, MerLion Research and MerLion Development. The MerLion Research unit is a contract services business, which provides access to natural product collections by offering sample/extract supply services, extract profiling and standardization, assay development, throughput screening, compound purification and structural identification, biocatalyst isolation, and strain improvement. The MerLion Development unit is progressing finafloxacin, a differentiated antibacterial candidate through phase II clinical trials, which is targ...

1 Science Park Road

05-01 The Capricorn

Singapore Science Park II

Singapore,  117528

Singapore

Founded in 2002

Phone:

65 6829 5600

Fax:

65 6829 5601

Key Executives for MerLion Pharmaceuticals Pte. Ltd.

Chief Executive Officer
Chief Operating Officer
Head of Research
Managing Director of MerLion Pharmaceuticals GmbH
Compensation as of Fiscal Year 2013.

MerLion Pharmaceuticals Pte. Ltd. Key Developments

MERLION Signs Distribution Agreement with RoomMates

MERLION announced signing of a distribution agreement with RoomMates. Production is located in Pennsylvania, York, USA. Company offers a unique range of license decals and also a wide choice of original designs of various subjects.

MerLion Pharmaceuticals Pte. Ltd. Appoints David Dally as Chief Executive Officer

MerLion Pharmaceuticals Pte. Ltd. announced the appointment of Mr. David Dally as Chief Executive Officer. Mr. Dally has been Chief Financial Officer of MerLion since February 2007. He has over 20 year's financial and commercial experience in the bio-medical industry, including senior roles with KuDOS Pharmaceuticals Ltd. and at Amersham plc. David will focus on developing strategic opportunities with both the systemic and topical formulations available within MerLion’s finafloxacin program.

MerLion Pharmaceuticals Pte. Ltd. Presents at EBD Group AG's Biotech showcase 2013, Jan-07-2013

MerLion Pharmaceuticals Pte. Ltd. Presents at EBD Group AG's Biotech showcase 2013, Jan-07-2013 . Venue: Parc 55 Wyndham Union Square Hotel, San Francisco, California, United States.

Similar Private Companies By Industry

Company Name Region
1st BASE Pte Ltd Asia
BRASS Pte Ltd. Asia
Luye Biotech (Singapore) Pte. Ltd. Asia
MerLion Pharmaceuticals Pte. Ltd. Asia
Aptuit (S) Pte Ltd. Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MerLion Pharmaceuticals Pte. Ltd., please visit www.merlionpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.